These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Management of venous access devices by Advanced Practice Nursing teams: more research needed. Goossens GA; Stas M; Moons P Eur J Oncol Nurs; 2012 Dec; 16(5):473-4. PubMed ID: 23039923 [No Abstract] [Full Text] [Related]
45. Long-term experience with a totally implanted catheter system in gynecologic oncologic patients. Koonings PP; Given FT J Am Coll Surg; 1994 Feb; 178(2):164-6. PubMed ID: 8173727 [TBL] [Abstract][Full Text] [Related]
46. [A subcutaneously implantable catheter in hematologic malignancy--a comparison with a conventional central venous catheter]. Engervall P; Björkholm M; Backman L; Spira J; Lindquist G; Wetterlöv C Lakartidningen; 1988 Sep; 85(36):2839-42. PubMed ID: 3059105 [No Abstract] [Full Text] [Related]
47. Blind percutaneous insertion of Hickman lines by a specialist team. Hanson JM; Challiss D; Primrose JN; Plusa SM Ann R Coll Surg Engl; 2001 Sep; 83(5):332-4. PubMed ID: 11806559 [TBL] [Abstract][Full Text] [Related]
48. Proactive placement of peripherally inserted central catheters. Harrold K; Martin A; Gale S Br J Nurs; 2015 Jul 23-Aug 12; 24(14):S16-7. PubMed ID: 26203695 [No Abstract] [Full Text] [Related]
49. [Update on implantable chambers]. Nahum S Soins Gerontol; 2006; (61):17-20. PubMed ID: 17063848 [No Abstract] [Full Text] [Related]
50. Experience with the intravenous totally implanted port in patients with gynecologic malignancies. Nelson BE; Mayer AR; Tseng PC; Schwartz PE Gynecol Oncol; 1994 Apr; 53(1):98-102. PubMed ID: 8175028 [TBL] [Abstract][Full Text] [Related]
51. A retrospective look at tip location and complications of peripherally inserted central catheter lines. James L; Bledsoe L; Hadaway LC J Intraven Nurs; 1993; 16(2):104-9. PubMed ID: 8478778 [TBL] [Abstract][Full Text] [Related]
52. [Permanent central venous catheters in oncologic patients]. Schrøder M; Pedersen IR; Rasmussen RB Ugeskr Laeger; 1991 Sep; 153(36):2491-4. PubMed ID: 1926604 [TBL] [Abstract][Full Text] [Related]
53. [Complications after insertion of a totally implantable venous access port in patients treated with chemotherapy for head and neck squamous cell carcinoma]. Hoareau-Gruchet F; Rtail R; Sulaj H; Khirnetkina A; Reyt E; Righini CA Ann Otolaryngol Chir Cervicofac; 2009 Apr; 126(2):43-52. PubMed ID: 19324328 [TBL] [Abstract][Full Text] [Related]
54. The use of bedside ultrasonography for PICC placement and insertion. Fidler HL Adv Neonatal Care; 2011 Feb; 11(1):52-3. PubMed ID: 21285657 [No Abstract] [Full Text] [Related]
55. Interval between port catheter flushing can be extended to four months. Ignatov A; Ignatov T; Taran A; Smith B; Costa SD; Bischoff J Gynecol Obstet Invest; 2010; 70(2):91-4. PubMed ID: 20224280 [TBL] [Abstract][Full Text] [Related]
57. The effect of a mediastinal mass on the initial positioning of a peripherally inserted central venous catheter. Tamburro RF; Conner DT; Proctor KE; Butler CL; Britton LR J Infus Nurs; 2003; 26(2):92-6. PubMed ID: 12642797 [TBL] [Abstract][Full Text] [Related]
58. Totally implantable venous catheters for chemotherapy: experience in 500 patients. Wolosker N; Yazbek G; Nishinari K; Malavolta LC; Munia MA; Langer M; Zerati AE Sao Paulo Med J; 2004 Jul; 122(4):147-51. PubMed ID: 15543368 [TBL] [Abstract][Full Text] [Related]
59. Do we need navigation systems in the vascular access practice? A case of peripherally inserted central catheter malposition. Konstantinou EA; Birbas K; Katsoulas TA; Karampinis DF; Mariolis-Sapsakos TD; Kaklamanos I; Bonatsos G J Vasc Access; 2014; 15(6):541-2. PubMed ID: 25041915 [No Abstract] [Full Text] [Related]